The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment

References

• Baumann P, Spies M, Moller HJ, Kasper S, Bitter I, Laux G. 2017. A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe. World J Biol Psychiatry. 18(1):29–38.
   PubMed Web of Science ®Google Scholar
• Best-Shaw L, Gudbrandsen M, Nagar J, Rose D, David AS, Patel MX. 2014. Psychiatrists’ perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring. Ther Drug Monit. 36(4):486–493. doi:10.1097/FTD.0000000000000041.
   PubMed Web of Science ®Google Scholar
• Brown JT, Bishop JR, Schneiderhan ME. 2020. Using pharmacogenomics and therapeutic drug monitoring to guide drug selection and dosing in outpatient mental health comprehensive medication management. Ment Health Clin. 10(4):254–258. doi:10.9740/mhc.2020.07.254.
   PubMedGoogle Scholar
• Carbon M, Correll CU. 2014. Clinical predictors of therapeutic response to antipsychotics in schizophrenia. Dialogues Clin Neurosci. 16(4):505–524. doi:10.31887/DCNS.2014.16.4/mcarbon.
   PubMed Web of Science ®Google Scholar
• Conca A, Schmidt E, Pastore M, Hiemke C, Duffy D, Giupponi G. 2011. Therapeutic drug monitoring in italian psychiatry. Pharmacopsychiatry. 44(6):259–262. doi:10.1055/s-0031-1286281.
   PubMed Web of Science ®Google Scholar
• Correll CU, Kim E, Sliwa JK, Hamm W, Gopal S, Mathews M, Venkatasubramanian R, Saklad SR. 2021. Pharmacokinetic characteristics of Long-Acting injectable antipsychotics for schizophrenia: an overview. CNS Drugs. 35(1):39–59. doi:10.1007/s40263-020-00779-5.
   PubMed Web of Science ®Google Scholar
• de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, Kopeček M, Švancer P, Olmos I, Ricciardi C, et al. 2022. An international adult guideline for making clozapine titration safer by using six Ancestry-Based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry. 55(2):73–86. doi:10.1055/a-1625-6388.
   PubMedGoogle Scholar
• Eryılmaz G, Hızlı Sayar G, Gül IG, Noyan CO, Özten E, Darçın AE, Yorbik Ö, Dilbaz N. 2015. Therapeutic drug monitoring: perspectives of psychiatrists in Turkey. Int J Psychiatry Clin Pract. 19(1):60–64. doi:10.3109/13651501.2014.981542.
   PubMed Web of Science ®Google Scholar
• Gómez-Carrillo A, Paquin V, Dumas G, Kirmayer LJ. 2023. Restoring the missing person to personalized medicine and precision psychiatry. Front Neurosci. 17:1041433. doi:10.3389/fnins.2023.1041433.
   PubMed Web of Science ®Google Scholar
• Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, et al. 2018. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 51(1-02):e1. doi:10.1055/s-0037-1600991.
   PubMed Web of Science ®Google Scholar
• Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJ, Birnbaum ML, Bloomfield MA, Bressan RA, Buchanan RW, Carpenter WT, et al. 2017. Treatment-Resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 174(3):216–229. doi:10.1176/appi.ajp.2016.16050503.
   PubMed Web of Science ®Google Scholar
• Jovanović N, Podlesek A, Volpe U, Barrett E, Ferrari S, Rojnic Kuzman M, Wuyts P, Papp S, Nawka A, Vaida A, et al. 2016. Burnout syndrome among psychiatric trainees in 22 countries: risk increased by long working hours, lack of supervision, and psychiatry not being first career choice. Eur Psychiatry. 32:34–41. doi:10.1016/j.eurpsy.2015.10.007.
   PubMed Web of Science ®Google Scholar
• Kaiser HF. 1974. An index of factorial simplicity. Psychometrika. 39(1):31–36. doi:10.1007/BF02291575.
   Web of Science ®Google Scholar
• Kilic O, Riecher-Rössler A, Galderisi S, Gorwood P, Frangou S, Pinto da Costa M. 2023. The role of gender as a barrier to the professional development of psychiatrists. Eur Psychiatr. 66(1):e89. doi:10.1192/j.eurpsy.2023.2462.
   PubMed Web of Science ®Google Scholar
• Kyllesø L, Smith RL, Karlstad Ø, Andreassen OA, Molden E. 2020. Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine. NPJ Schizophr. 6(1):17. doi:10.1038/s41537-020-0107-7.
   PubMed Web of Science ®Google Scholar
• Law S, Haddad PM, Chaudhry IB, Husain N, Drake RJ, Flanagan RJ, David AS, Patel MX. 2015. Antipsychotic therapeutic drug monitoring: psychiatrists’ attitudes and factors predicting likely future use. Ther Adv Psychopharmacol. 5(4):214–223. doi:10.1177/2045125315588032.
   PubMedGoogle Scholar
• Leucht S, Crippa A, Siafis S, Patel MX, Orsini N, Davis JM. 2020. Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia. Am J Psychiatry. 177(4):342–353. doi:10.1176/appi.ajp.2019.19010034.
   PubMed Web of Science ®Google Scholar
• Lopez LV, Shaikh A, Merson J, Greenberg J, Suckow RF, Kane JM. 2017. Accuracy of clinician assessments of medication status in the emergency setting: a comparison of clinician assessment of antipsychotic usage and plasma level determination. J Clin Psychopharmacol. 37(3):310–314. doi:10.1097/JCP.0000000000000697.
   PubMed Web of Science ®Google Scholar
• Mayerová M, Maslaňáková H, Ustohal L, Horská K. 2023. Clozapine-Associated myocarditis in a patient with poor metabolism during fast titration. J Clin Psychopharmacol. 43(2):186–187. doi:10.1097/JCP.0000000000001666.
   PubMed Web of Science ®Google Scholar
• McCutcheon RA, Pillinger T, Efthimiou O, Maslej M, Mulsant BH, Young AH, Cipriani A, Howes OD. 2022. Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta-analysis. World Psychiatry. 21(2):287–294. doi:10.1002/wps.20977.
   PubMed Web of Science ®Google Scholar
• Paulzen M, Haen E, Stegmann B, Unterecker S, Hiemke C, Grunder G, Schoretsanitis G. 2017. Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns. Europ Arch Psychiatry Clin Neurosci. 267(4):325–333.
   PubMed Web of Science ®Google Scholar
• Remington G, Addington D, Honer W, Ismail Z, Raedler T, Teehan M. 2017. Guidelines for the pharmacotherapy of schizophrenia in adults. Canadian Journal of Psychiatry Revue Canadienne de Psychiatrie. 62(9):604–616.
   PubMed Web of Science ®Google Scholar
• Schoretsanitis G, (Guest Editor) 2024. Establishing and extending the use of therapeutic drug monitoring in neuropsychopharmacology. Ther Drug Monit. 46(2):141–142. doi:10.1097/FTD.0000000000001171.
   PubMed Web of Science ®Google Scholar
• Schoretsanitis G, de Leon J, Diaz FJ. 2018. Prolactin levels: sex differences in the effects of risperidone, 9-hydroxyrisperidone levels, CYP2D6 and ABCB1 variants. Pharmacogenomics. 19(10):815–823. doi:10.2217/pgs-2018-0053.
   PubMed Web of Science ®Google Scholar
• Schoretsanitis G, Haen E, Gründer G, Stegmann B, Schruers KRJ, Hiemke C, Lammertz SE, Paulzen M. 2016. Pharmacokinetic drug-drug interactions of mood stabilizers and risperidone in patients under combined treatment. J Clin Psychopharmacol. 36(6):554–561. doi:10.1097/JCP.0000000000000601.
   PubMed Web of Science ®Google Scholar
• Schoretsanitis G, Kane JM, Correll CU, Marder SR, Citrome L, Newcomer JW, Robinson DG, Goff DC, Kelly DL, Freudenreich O, et al. 2020. Blood levels to optimize antipsychotic treatment in clinical practice: a joint consensus statement of the American society of clinical psychopharmacology and the therapeutic drug monitoring task force of the arbeitsgemeinschaft fur neuropsychopharmakologie und pharmakopsychiatrie. J Clin Psychiatry. 81(3):19cs13169. doi:10.4088/JCP.19cs13169.
   PubMed Web of Science ®Google Scholar
• Schoretsanitis G, Meyer JM, Conca A, Hiemke C. 2023. Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerations. Expert Opin Drug Metab Toxicol. 19(4):189–202. doi:10.1080/17425255.2023.2220962.
   PubMed Web of Science ®Google Scholar
• Siafis S, Wu H, Wang D, Burschinski A, Nomura N, Takeuchi H, Schneider-Thoma J, Davis JM, Leucht S. 2023. Antipsychotic dose, dopamine D2 receptor occupancy and extrapyramidal side-effects: a systematic review and dose-response meta-analysis. Mol Psychiatry. 28(8):3267–3277. doi:10.1038/s41380-023-02203-y.
   PubMed Web of Science ®Google Scholar
• The World Bank Group. 2024. World Bank country and lending groups.]. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.
   Google Scholar
• Tveito M, Høiseth G, Haslemo T, Molden E, Smith RL. 2021. Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations-an observational study using blood samples from 1223 patients. Eur J Clin Pharmacol. 77(8):1201–1208. doi:10.1007/s00228-021-03114-z.
   PubMed Web of Science ®Google Scholar
• Urban AE, Cubała WJ. 2017. Therapeutic drug monitoring of atypical antipsychotics. Psychiatr Pol. 51(6):1059–1077. doi:10.12740/PP/65307.
   PubMed Web of Science ®Google Scholar
• Vincent PD, Lesage A, Lalonde P, Lipp O, De Guire V, Desbiens MP, Schoretsanitis G. 2024. A short turnaround of clozapine blood level results within 6 hours is essential for effective management of severely ill persons with treatment-Resistant schizophrenia. Ther Drug Monit. 46(2):274–275. doi:10.1097/FTD.0000000000001188.
   PubMed Web of Science ®Google Scholar
• Wu H, Siafis S, Wang D, Burschinski A, Schneider-Thoma J, Priller J, Davis JM, Leucht S. 2023. Antipsychotic-induced akathisia in adults with acute schizophrenia: a systematic review and dose-response meta-analysis. Eur Neuropsychopharmacol. 72:40–49. doi:10.1016/j.euroneuro.2023.03.015.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li C, Huhn M, Rothe P, Krause M, Bighelli I, Schneider-Thoma J, Leucht S. 2017. How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 27(9):835–844. doi:10.1016/j.euroneuro.2017.06.011.
   PubMed Web of Science ®Google Scholar